Waldenström Macroglobulinemia, an Issue of Hematology/Oncology Clinics of North America

Volume 37-4
Herausgeber: Castillo, Jorge J; Sarosiek, Shayna; Kapoor, Prashant

• Gebundenes Buch

Produktbeschreibung

In this issue of Hematology/Oncology Clinics, guest editors Drs. Jorge J. Castillo, Prashant Kapoor, and Shayna Sarosiek bring their considerable expertise to the topic of Waldenström Macroglobulinemia. Top experts in the field provide a focused update on the biology, diagnosis and management, and novel therapies for patients with Waldenström macroglobulinemia, a rare blood cell cancer characterized by an excess of abnormal white blood cells in the bone marrow. * Contains 14 practice-oriented topics including clinical implications of genomic profile in Waldenström macroglobulinemia; chemoimmunotherapy regimens in the frontline management of Waldenström macroglobulinemia; management of relapsed or refractory Waldenström macroglobulinemia; evaluation and management of aggressive transformation in Waldenström macroglobulinemia; management of Waldenström macroglobulinemia in limited-resource settings; and more.  * Provides in-depth clinical reviews of Waldenström macroglobulinemia, offering actionable insights for clinical practice.  * Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews. 

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Health Sciences
• Seitenzahl: 240
• Erscheinungstermin: 30. Juni 2023
• Englisch
• Abmessung: 229mm x 152mm
• Gewicht: 410g
• ISBN-13: 9780443182983
• ISBN-10: 0443182981
• Artikelnr.: 67444793

Inhaltsangabe

Clinical Implications of Genomic Profile in Waldenström Macroglobulinemia
Frontline Management of Waldenström Macroglobulinemia with
Chemoimmunotherapy Proteasome Inhibitor-Based Regimens in the Frontline
Management of Waldenström Macroglobulinemia BTK Inhibitors in the Frontline
Management of Waldenström Macroglobulinemia Future Directions in the
Frontline Management of Waldenström Macroglobulinemia The Management of
Relapsed or Refractory Waldenström's Macroglobulinemia Novel Agents in
Waldenström Macroglobulinemia Investigation and Management of
Immunoglobulin M- and Waldenström-Associated Peripheral Neuropathies
Evaluation and Management of Bing-Neel Syndrome Evaluation and Management
of Disease Transformation in Waldenström Macroglobulinemia Management of
Waldenström Macroglobulinemia in Limited-Resource Settings